Article
The challenges associated with molecular targeted therapies for glioblastoma.
Journal of neuro-oncology - 1 May 2016
Jue Toni Rose, McDonald Kerrie L
Abstract excerpt
Glioblastoma (GBM) is the most aggressive malignant brain tumor in adults. Improvements in the treatment of GBM have remained static since the advent of the standard therapy which includes radiation with concurrent and adjuvant temozolomide treatment. Developing treatment and diagnostic or companion biomarker combinations is transforming the way we treat numerous cancers. However, can this emerging paradigm be...
Topics
- Antineoplastic Agents
- Brain Neoplasms
- Glioblastoma
- Humans
- Molecular Targeted Therapy
- Mutation
- Neoplasm Proteins
